PECULIARITIES OF THE STRUCTURAL AND FUNCTIONAL STATE OF THE HEART IN PATIENTS AT DIFFERENT STAGES OF CEREBRAL ATHEROSCLEROSIS

V. E. Kondratyuk; M. S. Yehorova

V. E. Kondratyuk Bogomolets National Medical University, 13 Т. Shevchenko blvd., Kyiv, Ukraine, 01601
M. S. Yehorova Institute of Endocrinology and Metabolism named after V. P. Komisarenko of the NAMS of Ukraine, 69 Vyshgorodskaya str, Kyiv, Ukraine, 04114

Keywords: cerebral atherosclerosis, left ventricular geometry, hemispheric differences.

Abstract

Cerebrovascular diseases is one of the most important causes of morbidity and mortality in the adult population.

Objective: to conduct a comparative analysis of the morpho-functional changes of the heart, intracardiac and systemic hemodynamics in elderly patients with cerebral atherosclerosis (CA) of 1–3 degree.

Materials and methods: 229 patients with cerebral atherosclerosis of 2–3 degree took part in a comprehensive study. The patients were divided into 4 groups: Group 1 – patients with ischemic stroke (IS) in the right hemisphere (RH), Group 2 – with IS in the left hemisphere (LH), Group 3 – with cerebral atherosclerosis of 1–2 degree (no IS – comparison group) and Group 4 – a general group of patients who have IS. Design: simple, prospective, non-randomized, with the consistent inclusion of patients.

Results and discussion: The compared groups differed statistically significantly by the LA diameter index (ILA), the LV diastolic index (LVIDd), the LV systolic index (LVIDs) and the wall thickness of the left ventricle (LV). Thus, the highest ILA value was observed in patients with CA (1.1 times more than in patients with IS), the highest values of LVIDd and LVIDs – in the group of patients with left-hemispheric localization of IS (1.14 and 1.18 times more, accordingly, than in patients with CA without IS). The minimal thickness of the interventricular septum (IVS) and the posterior wall of the LV was in the group of patients with CA (1.18 and 1.17 times less, respectively, compared with the group of patients with AI, without taking into account the hemispheric localization of IS). Interhemispheric differences were observed only in the assessment of LVIDd, LVIDs, and the thickness of the IVS. So, in patients with left hemispheric localization of IF LVIDd, it was 1.09 times greater, and LVIDs was 1.16 times greater than in patients with right hemispheric IF, while the IVS was 1.15 times thicker in the IS group with the right hemisphere than with left hemispheric localization of IF. In the compared groups, we also observed statistically significant differences in the assessment of the parameters of systemic and intracardiac hemodynamics. So, in patients with CA, the index of the end-diastolic volume (iEDV) was 1.14 times higher and the index of the end-systolic volume (iESV) was 1.09 times less than in patients with IS, while in patients with left-hemispheric localization of IS the lowest ejection fraction and iEDV were observed compared with the group of patients with CA (1.02 and 1.15 times, respectively). Interhemispheric differences were recorded only in terms of the magnitude of the stroke index (SI). Thus, patients with IS in LН SI was 1.2 times more than in patients with IS in RH. In the group of patients with CA and IS, non-dilatational eccentric and concentric hypertrophy of LV (LVH) was most common (37.4 % and 48.1 %–26.0 % and 61.6 %, respectively), but type III was 1.44 times more common in patients with CA, and type V – 1.28 times more often in patients with IS. Eccentric dilated LVH was most often observed in patients with IS – 2.2 times more often than in patients with CA, and concentric dilated LVH was more common in patients with CA – 1.8 times more often than in patients with IS. Interhemispheric differences were observed only in relation to types III and V LVH. Thus, in patients with right hemispheric localization of IF, concentric non-dilated LVH was 1.66 times more common, and in patients with left-hemispheric IF localization – 4.4 times eccentric non-dilated LVH.

Conclusions: in patients with CA of 1–3 degree, there were statistically significant differences in the morpho-functional changes in the heart, intracardiac and systemic hemodynamics and LV geometry, and some of these differences were hemispheric.

Downloads

Download data is not yet available.

References

1. Badimon L, Vilahur G. Thrombosis for-mation on atherosclerotic lesions and plaque rupture. Journal of Internal Medicine. 2014;276(6):618–632.
2. Bangalore S, Gong Y, Cooper-DeHoff R.M. et al. 2014 Eighth Joint National Committee Panel recommendations for blood pressure targets revisited: Results from the INVEST study. J. Am. Coll. Cardiol. 2014, 64:784–793.
3. Den Hartog AG, Achterberg S, Moll F.L, Kappelle L.J, Visseren F.L.J, van der Graaf Y, Algra A, SMART Study Group. Asymptomatic carotid artery stenosis and the risk of ischemic stroke according to subtype in patients with clinically manifest arterial disease. Stroke. 2013;44:1002–1007.
4. Fokin VF. [Sovremennyie napravleniya izucheniya funktsionalnoy mezhpolusharnoy asimmetrii]. Funktsionalnaya mezhpo¬lusharnaya asimmetriya i plastichnost mozga. Materialyi Vseros. konf. s mezhd. Uchastiem. Мoscow, 2012, pp. 185–190.
5. Gradman AH. Optimal blood pressure tar-gets in older adults. How low is low enough? J. Am. Coll. Cardiol. 2014; 64:794–796.
6. Jauch EC, Saver JL, Adams HP. et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke. Stroke. 2013; 44(3):870–947.
7. Kernan WN, Ovbiagele B, Black HR. et al. Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Is-chemic Attack. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 2160–2236.
8. Li H, Förstermann U. Uncoupling of endo-thelial NO synthase in atherosclerosis and vascular disease. Current Opinion in Pharmacology. 2013;13(2):161–167.
9. Piradov MA, Domashenko MA, Maksi-mova MY. Reperfusion therapies for is-chemic stroke. In: Piradov MA, Illariosh-kin SN, Tanashyan MM, editors. Nevrologiya XXI veka: diagnosticheskie, lechebnye i issledovatel'skie tekhnologii: Rukovodstvo dlya vrachei [Neurology of the XXI century: diagnostic, medical and research technology: a Guide for physi-cians]. Vol. 2. Moscow: ATMO; 2015, 400 p.
10. Powers WJ, Derdeyn CP, Jauch EC et al. American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Manage-ment of Patients with Acute Ischemic Stroke Regarding Endovascular Treat-ment. A Guideline for Healthcare Profes-sionals From the American Heart Associa-tion/American Stroke Association. Stroke; 2015; 46(10):3020–35.
11. Prevalence and determinants of left ven-tricular geometric abnormalities in hyper-tensive patients: A study based on the up-dated classification system of left ventricular geometry Hellenic. J Cardiol. 2017;58(2):124–132.
12. Riecker A, Grschel K, Ackermann H. et al. The role of the unaffected hemisphere in motor recovery after stroke. Hum Brain Mapp. 2010; 31:1017–1029.
13. Suslina ZA, Fonyakin AV, editors. Kardi-onevrologiya. Spravochnoe rukovodstvo s obzorom klinicheskikh issledovanii [Car-dioneurology. Reference manual with the review of clinical research]. Moscow: IMA-PRESS; 2011. 264 p.
14. Suslina ZA, Gulevskaya TS, Maksimova MY, Morgunov VA. Narusheniya mozgovogo krovo¬obrashcheniya. Diagnostika, lechenie, profilaktika [Violations of cerebral circulation. Diagnosis, treatment, prevention]. Moscow: MEDpress-inform; 2016. 536 p.
15. Tanashyan MM, Lagoda OV, Gulevskaya TS, Maksyutkina LN, Raskurazhev AA. Progressiruyuschiy tserebralnyiy ateroskleroz: klinicheskie, biohimicheskie i morfologicheskie aspektyi. Annalyi klinicheskoy i eksperimentalnoy nevrologii. 2013;7(4):4–9.
16. Tanashyan MM, Raskurazhev AA, Sha-balina AA, Lagoda OV, Gnedovskaya EV. Biomarkeryi tserebralnogo ateroskleroza: vozmozhnosti ranney diagnostiki i prognozirovaniya individualnogo riska. Annalyi klinicheskoy i eksperimentalnoy nevrologii. 2015;9(3):20–25.